Untitled Document

Why We Do It Page Banner

Why We Do It

MDCorp has long recognized that Asia is the home for more than 50% of the world’s population, yet healthcare spending per-capita remains some 75% below developed country averages.

MDCorp recognizes that novel therapeutics and world class technology development and innovation create a very high-pain environment if basic technology remains undeveloped and thus the local market perpetually undeserved.

MDCorp uses its network, owned technology, distribution and brand equity to more rapidly develop med-tech and biotechnology solutions in the local market making MDCorp one of the most unique investment platforms through which we can accelerate local market product development and by extension, product distribution.